NDC 51672-2116-0 - Feverall Jr. Strength
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 51672-2116
- Requested NDC
- 51672-2116-0
- Package NDCs from labels
- 51672-2116-0, 51672-2116-2, 51672-2116-4
- Manufacturer
- Sun Pharmaceutical Industries, Inc. | Cosette Pharmaceuticals NC Laboratories, LLC
- Effective date
- 2026-09-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| FeverAll ® Jr. Strength | Sun Pharmaceutical Industries, Inc. | Cosette Pharmaceuticals NC Laboratories, LLC | 2026-09-03 | HUMAN OTC DRUG LABEL |
| Feverall Jr. Strength - Bryant Ranch Prepack | Bryant Ranch Prepack | 2025-01-28 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 51672-2116-0 | Feverall Jr. Strength | 1 in 1 BLISTER PACK | SUPPOSITORY | 1 | 7 | |
| 51672-2116-2 | Feverall Jr. Strength | 6 in 1 CARTON | SUPPOSITORY | 6 | 7 | |
| 51672-2116-4 | Feverall Jr. Strength | 50 in 1 CARTON | SUPPOSITORY | 50 | 7 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 51672-2116 | FEVERALL JR. STRENGTH (ACETAMINOPHEN) SUPPOSITORY [TARO PHARMACEUTICALS U.S.A. INC.] | 6 | Current NDC, Legacy NDC, 3 package rows | 20241222_3561bbc3-53b0-4857-8b71-39e165ed95ce.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 51672-2116-2 | EA - Each | 51672-2116 | fe61d879-44ce-47fd-bdf9-0adaffd7ae79 | 1 | 2014-09-03 |
| 51672-2116-4 | EA - Each | 51672-2116 | 8714140c-e1ea-469e-935e-2209831099f2 | 1 | 2014-09-03 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| Acetaminophen | ACTIVE INGREDIENT | 362O9ITL9D | FEVERALL JR. STRENGTH (ACETAMINOPHEN) SUPPOSITORY [TARO PHARMACEUTICALS U.S.A. INC.] | 2 | |
| Acetaminophen | ACTIVE MOIETY | 362O9ITL9D | FEVERALL JR. STRENGTH (ACETAMINOPHEN) SUPPOSITORY [TARO PHARMACEUTICALS U.S.A. INC.] | 2 | |
| glyceryl monostearate | INACTIVE INGREDIENT | 230OU9XXE4 | FEVERALL JR. STRENGTH (ACETAMINOPHEN) SUPPOSITORY [TARO PHARMACEUTICALS U.S.A. INC.] | 2 | |
| hydrogenated palm kernel oil | INACTIVE INGREDIENT | FM8D1RE2VP | FEVERALL JR. STRENGTH (ACETAMINOPHEN) SUPPOSITORY [TARO PHARMACEUTICALS U.S.A. INC.] | 2 | |
| PEG-100 stearate | INACTIVE INGREDIENT | YD01N1999R | FEVERALL JR. STRENGTH (ACETAMINOPHEN) SUPPOSITORY [TARO PHARMACEUTICALS U.S.A. INC.] | 2 | |
| polysorbate 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | FEVERALL JR. STRENGTH (ACETAMINOPHEN) SUPPOSITORY [TARO PHARMACEUTICALS U.S.A. INC.] | 2 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| ACETAMINOPHEN AND CODEINE PHOSPHATE | ACETAMINOPHEN AND CODEINE PHOSPHATE | REMEDYREPACK INC. | 1fe39679-fd58-4d2c-ba61-49d492a2b087 | 2026-09-28 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| ACETAMINOPHEN AND CODEINE PHOSPHATE | ACETAMINOPHEN AND CODEINE PHOSPHATE | REMEDYREPACK INC. | 4c966d73-77c6-4514-954e-57aa06a080c6 | 2026-09-28 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| Cold and Flu plus Congestion Nighttime | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, DOXYLAMINE SUCCINATE, PHENYLEPHRINE HCL | WALMART INC. | 1236b463-0073-44b5-a516-5b7c06a40887 | 2026-09-28 | Warnings | 362O9ITL9D |
| Butalbital, Acetaminophen and Caffeine | BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE | Genus Lifesciences Inc. | 5f603b0d-69e5-4c02-b6b3-b4705e243e9a | 2026-09-25 | Boxed warning, Warnings, Adverse reactions | 362O9ITL9D |
| DAYTIME COLD AND FLU | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | Amazon.com Services LLC | 692a9fa1-b251-489e-8978-3ed92e192d08 | 2026-09-24 | Warnings | 362O9ITL9D |
| TYLENOL Cold Plus Flu Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Kenvue Brands LLC | efb3bfc5-72e9-4221-8d03-e48f3d8e3821 | 2026-09-24 | Warnings | 362O9ITL9D |
| Sinus Severe | ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Harris Teeter | ba59657e-a16e-46b2-998d-45dd71095d7a | 2026-09-24 | Warnings | 362O9ITL9D |
| Sinus Pressure plus Pain PE | ACETAMINOPHEN AND PHENYLEPHRINE HYDROCHLORIDE | Harris Teeter | e9a3cb81-2d45-4fc2-80f9-7fde71b3e81d | 2026-09-24 | Warnings | 362O9ITL9D |
| Cold Flu Severe | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | Harris Teeter | 590c699a-9d87-43db-aef4-2615af07a6b6 | 2026-09-24 | Warnings | 362O9ITL9D |
| Head Congestion plus Flu Severe PE | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | HARRIS TEETER | e33b8911-5f5c-c037-e053-2a95a90adb2e | 2026-09-24 | Warnings | 362O9ITL9D |
| Mucus Relief Cold Flu and Sore Throat | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | HARRIS TEETER | b2090b31-dc0a-2cd4-e053-2a95a90a414e | 2026-09-24 | Warnings | 362O9ITL9D |
| Mucus Relief Sinus Pressure Pain and Cough | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE | HARRIS TEETER | e547024f-fbf0-fc9a-e053-2995a90afe19 | 2026-09-24 | Warnings | 362O9ITL9D |
| Acetaminophen, Guaifenesin, Dextromethorphan HBr, Phenylephrine HCl | ACETAMINOPHEN, GUAIFENESIN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL | OPMX LLC | 9a164cfc-b623-9a9f-e053-2a95a90a0173 | 2026-09-24 | Warnings | 362O9ITL9D |
| SEDAL3X | ACETAMINOPHEN, ASPIRIN, CAFFEINE | OPMX LLC | e9089f8b-3d23-5c81-e053-2995a90a4202 | 2026-09-24 | Warnings | 362O9ITL9D |
| Tesalon Jarabe Adulto | ACETAMINOPHEN, DEXTROMETHORPHAN HBR, GUAIFENESIN USP, PHENYLEPHRINE HCL | OPMX LLC | 231c6455-4198-feec-e063-6394a90a8541 | 2026-09-24 | Warnings | 362O9ITL9D |
| Temperal-ito | ACETAMINOPHEN | OPMX Chula Vista | fd2d85a0-4bc6-3ed0-e053-6294a90a8494 | 2026-09-24 | Warnings | 362O9ITL9D |
| Acetaminophen | ACETAMINOPHEN | OPMX LLC | 5b8a92c9-47c0-4438-a49d-b3878f7afd73 | 2026-09-24 | Warnings | 362O9ITL9D |
| Neo-Lubrina | ACETAMINOPHEN | OPMX Chula Vista | fd3ca168-23b9-3eb8-e053-6394a90ac89b | 2026-09-24 | Warnings | 362O9ITL9D |
| Pentrexcilina Children TOTAL RELIEF Multi-Symptom | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN USP, PHENYLEPHRINE HYDROCHLORIDE | OPMX LLC | 2bc10608-ddba-1e68-e063-6294a90aef67 | 2026-09-24 | Warnings | 362O9ITL9D |
| Pentrexcilina Adult TOTAL RELIEF Multi-Symptom | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN USP, PHENYLEPHRINE HYDROCHLORIDE | OPMX LLC | 2bef3b6f-456a-5b76-e063-6394a90aa116 | 2026-09-24 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.